Table 2.
Amyloid PET Analyses
Model 1 | Model 2 | Model 3 | |||||||
---|---|---|---|---|---|---|---|---|---|
| |||||||||
ηp2 | Estimate [95% CI] | p | ηp2 | Estimate [95% CI] | p | ηp2 | Estimate [95% CI] | p | |
| |||||||||
Global PIB SUVR | |||||||||
Sex | .043 | 0.145 [0.018, 0.272] | .025 | .030 | 0.125 [−0.007, 0.256] | .063 | .023 | 0.110 [−0.025, 0.246] | .11 |
Temporal Meta-ROI FTP SUVR | .012 | 0.094 [−0.064, 0.251] | .24 | .013 | 0.099 [−0.062, 0.260] | .23 | |||
APOE4 a | .003 | 0.036 [−0.095, 0.168] | .59 |
All models controlled for age and Clinical Dementia Rating Sum of Boxes. Reference levels are male and ε4 non-carrier for sex and APOE4 status, respectively. ηp2: partial eta-squared.
APOE data available on 56 males and 59 females. APOE4 is coded as either an ε4 carrier or non-carrier.
Models 1 and 2 have a total n=119, while Model 3 has a total n=115.